Delivery Order SPE2DB22D1106-SPE2DB25FFAR8
Award Date 7/30/25
Potential Completion Date 8/20/25
Potential Value $7.6K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $5,078.08 delivery order to AmerisourceBergen Drug Corp for CABENUVA ER 400 mg-600 mg suspension in 4 mL formulation, with an ultimate completion date of August 20, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. CABENUVA is a long-acting injectable antiretroviral medication used in HIV treatment, reflecting the breadth of...
- The Defense Logistics Agency awarded a delivery order valued at $22,901.40 to AmerisourceBergen Drug Corp for CABENUVA ER 600 mg-900 mg suspension in 6 ml quantities. This is a firm fixed price, competitively awarded delivery order with an ultimate completion date of August 15, 2025. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and represents a child order under a larger contracting vehicle. No set-aside designation was applied to this...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $45,802.80 on August 1, 2025, for the supply of CABENUVA ER 600 mg-900 mg suspension in 6 mL units. This firm fixed-price delivery order, which has no set-aside designation, is scheduled for completion by August 22, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a competitive procurement action under the company's...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $11,804.40 firm fixed-price delivery order is for the supply of CABENUVA ER 600 MG-900 MG SUSP 6ML, a specialty medication, with a performance period through December 11, 2024. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, which serves as a primary vehicle...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $22,901.40 firm-fixed-price contract is for the delivery of CABENUVA ER 600 MG-900 MG SUSP 6ML, a pharmaceutical product. The contract has a period of performance through May 28, 2025 and is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a $999,999,999.00 Indefinite Delivery...
- This federal contract award is for the delivery of CABENUVA ER 600 MG-900 MG SUSP 6ML, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $22,820.10, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through November...
- The Defense Logistics Agency awarded a $7,829.46 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4562226877 CABENUVA ER 600 MG-900 MG SUSP 6ML. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the requested pharmaceutical product from its Conshohocken, Pennsylvania facility on behalf of the Defense Logistics Agency, the logistics combat support agency of the United States Department of Defense. No subcontractors or set aside...
- This federal contract award is a delivery order with a firm fixed price of $7,869.62 issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the supply of 4566640318 - CABENUVA ER 600 MG-900 MG SUSP 6ML, a pharmaceutical product. The contract has an ultimate completion date of December 30, 2024 and was awarded on December 6, 2024. The contract was issued by the Defense Logistics Agency (DLA), a defense agency that provides...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of CABENUVA ER 600 MG-900 MG SUSP 6ML, a pharmaceutical product, with a ceiling value of $3,803.35. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA, valued at $999,999,999 and running through November 2026. The IDC...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $22,820.10 firm fixed-price contract is for the delivery of CABENUVA ER 600 MG-900 MG SUSP 6ML, a pharmaceutical product, with a period of performance through July 16, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract...